Prucalopride, a 5-HT4 serotonin receptor agonist, has won FDA approval for treating adults with chronic idiopathic constipation, said manufacturer Shire.
Prucalopride, a 5-HT4 serotonin receptor agonist, has won FDA approval for treating adults with chronic idiopathic constipation, said manufacturer Shire.